Next Article in Journal
Serological Survey of Mosquito-Borne Arboviruses in Wild Birds from Important Migratory Hotspots in Romania
Previous Article in Journal
Risk Factors for the Development of Post-Infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Detection of Lotmaria passim and Crithidia mellificae in Selected Bumblebee Species
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Natural Substances, Probiotics, and Synthetic Agents in the Treatment and Prevention of Honeybee Nosemosis

by
Magdalena Kunat-Budzyńska
1,
Michał Budzyński
1,
Michał Schulz
2,
Aneta Strachecka
2,
Marek Gancarz
3,4,
Robert Rusinek
4 and
Aneta A. Ptaszyńska
1,*
1
Department of Immunobiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland
2
Department of Invertebrate Ecophysiology and Experimental Biology, University of Life Sciences in Lublin, Doświadczalna 50a, 20-280 Lublin, Poland
3
Faculty of Production and Power Engineering, University of Agriculture in Krakow, Balicka 116B, 30-149 Krakow, Poland
4
Institute of Agrophysics Polish Academy of Sciences, Doświadczalna 4, 20-290 Lublin, Poland
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(11), 1269; https://doi.org/10.3390/pathogens11111269
Submission received: 29 August 2022 / Revised: 27 October 2022 / Accepted: 27 October 2022 / Published: 31 October 2022
(This article belongs to the Special Issue Novel Insights into Honeybee Virus and Other Pathogens)

Abstract

:
Honeybees are important pollinators, but they are continuously exposed to a variety of fungal and bacterial diseases. One of the various diseases affecting honeybees is nosemosis caused by microsporidia from the Nosema genus. Honeybees are mainly infected through consumption of infected food or faeces containing Nosema spp. spores. Nosemosis causes damage to the middle intestine epithelium, which leads to food absorption disorders and honeybee malnutrition. Fumagillin, i.e., the antibiotic used to treat nosemosis, was withdrawn in 2016 from EU countries. Therefore, researchers have been looking for compounds of both natural and synthetic origin to fight nosemosis. Such compounds should not have a negative impact on bees but is expected to inhibit the disease. Natural compounds tested against nosemosis include, e.g., essential oils (EOs), plant extracts, propolis, and bacterial metabolites, while synthetic substances tested as anti-nosemosis agents are represented by porphyrins, vitamins, antibiotics, phenolic, ascorbic acids, and others. This publication presents an 18-year overview of various studies of a number of natural and synthetic compounds used in the treatment and prevention of nosemosis cited in PubMed, GoogleScholar, and CrossRef.

Graphical Abstract

1. Nosemosis

The honeybee Apis mellifera Linnaeus (Hymenoptera: Apidae) is an important crop pollinator around the world. It also contributes to the protection of biodiversity of many insect-pollinated plants [1]. Moreover, it provides many food products, including honey, royal jelly, or bee pollen with healing properties [2,3].
The honeybee is a genetically diverse species. The four main evolutionary lines of these insects, distinguished based on morphology and molecular markers, include line A (areas of Africa), line O (Middle East), line C (Central Europe), and line M (Western and Northern Europe) [4,5]. Recently, the number of bee colonies has been decreasing due to the weather conditions, environmental stress, use of pesticides, and various pathogens, including the Varroa destructor mite, the Paenibacillus larvae bacterium, and microsporidia from the Nosema genus attacking honeybees [3,6].
Due to the lack of mitochondria and the presence of 16S SSU rRNA, Nosema spp. were first classified as protozoa; however, more detailed research has revealed that these organisms are representatives of the Fungi kingdom [7]. Until recently, there were two causative agents of nosemosis, i.e., Nosema apis and N. ceranae [8,9]; however, the third species, N. neumanni, was described in Apis mellifera in 2017 [10]. Nosema apis is a well-known microorganism, which was already described in 1909 by German biologist Zander [8,11]. Nosema ceranae was originally detected in Apis cerana in Asia in 1996 [12] and soon in A. mellifera [13]. Later studies conducted using polymerase chain reaction (PCR) showed that Nosema ceranae was present in honeybees around the world in earlier years [14]. Nowadays, N. neumanni is only observed in Uganda, where its incidence was found to be much higher than that of the two other Nosema species [10]. Nevertheless, since the N. ceranae from Taiwan was able to infect honeybees worldwide, the potential threat of N. neumanni invasion should be carefully monitored.
Honeybee workers can be infected by ingestion of redundant spores of Nosema spp. which are found in faeces. Faeces of infected bees are rich in undigested sugars; hence, they are readily licked by other bees. Spores present in the middle intestine attack epithelial cells and can cover the whole intestine lumen, thus disturbing its functions [15]. The middle intestine of the honeybee is the focal point of nutrient absorption [16]. Therefore, the production of digestive enzymes and the proper absorption of food compounds in the middle intestine are disturbed [11,16,17,18,19]. The life cycle of Nosema spp. is shown in Figure 1.
Fumagillin isolated from the fungus Aspergillus fumigatus was an antibiotic used to treat nosemosis [20]. The approved antibiotic preparation was Fumagilin-B, also known as Fumidil-B ®, which contained dicyclohexylamine in addition to fumagillin. Since the invention of this antibiotic by Hanson and Eble [21], it has been used to treat infections caused by N. apis [22,23]. The mechanism of action of fumagillin is to inhibit the activity of the enzyme methionine aminopeptidase MetAP-2 [24]. Studies have shown that the use of fumagillin at the dose recommended by the manufacturer reduced the intensity or completely eliminated the infection [25,26]. However, the reduction in the therapeutic dose showed that N. cerenae was less sensitive to this antibiotic than N. apis. As reported by Huang et al. [27], Nosema ceranae escapes fumagillin control and can show resistance to this antibiotic. Fumagillin was withdrawn in 2016 by the European Medicines Agency due to the penetration of fumagillin residues into honey and other bee products, which can be dangerous for consumers of honey and bee products [24,28]. Therefore, there is a high demand to search for other ways to treat nosemosis.

2. Natural Substances

2.1. Essential Oils

Therapies based on natural compounds can contribute to the control of nosemosis development in honeybees. An alternative to synthetic compounds can be essential oils (EOs), i.e., complex mixtures usually extracted from plants using steam distillation and various solvents such as water, ethanol, phenol, and others [29]. EOs are used in apiculture due to their emollient, calming, carminative, antispasmodic, antiseptic, and antimicrobial properties [30,31,32].
One of such preparations was Supresor1, a mixture of EOs derived from mint (Mentha pepper L.), lemon balm (Melissa officinalis L.), coriander (Coriander sativum L.), and thyme (Satureja hortensis L.) [30]. According to OECD, the product is practically non-toxic [33], and has been classified into toxicity group 5. According to the Hodge and Sterner (OECD) scale, toxicity group 5 is characterised by the LD 50 value of 5000-15,000 mg/kg [33]. The most effective dose of Supresor1 was 5 mL per 1 L of sugar syrup. This dose used in laboratory experiments led to an 80% reduction in the number of Nosema spp. spores in comparison to the control group. Furthermore, even higher concentrations of the preparation did not exert side effects on bees [30].
EOs obtained from Chilean acorn Cryptocarya alba (Molina) Looser can be used to control nosemosis as well. The dose of 4 μg per bee was not toxic but effective. Furthermore, the crude extract was more effective than the application of chemically obtained single compounds from C. alba, i.e., β-phellandrene, eucalyptol, and α-terpineol [20]. Methanolic extracts (2 to 16%) from other Chilean native plants, Aristotelia chilensis (Molina) Stuntz and Ugni molinae Turcz., which are rich in rutin and myricetin, also gave promising effects. Nosemosis treatment with EOs from these two plants and propolis decreased the N. ceranae spore load and prolonged the honeybee lifespan [34].
Another herbal mixture whose effectiveness was tested on Nosema apis, Nosema ceranae, and mixed infections with both was HEOEM (herbal essential oil extract mixture). HEOEM includes extracts from the following plants: Rumex acetosella L., Achillea millefolium L., Plantago lanceolata L., Salvia officinalis L., Thymus vulgaris L., Rosmarinus officinalis L., and Laurus nobilis L. Such a herbal mixture was created due to the chemical composition, the content of biologically active compounds, and the biological activity of these plants. The experiments with the use of HEOEM lasted 3 weeks and were carried out in laboratory conditions in standard cages and in an apiary. Özkırım and Küçüközmen [35] determined the effective dose at 500 ul of HEOEM solution in sugar syrup in laboratory conditions and 2000 ul per frame in an apiary. The results revealed the highest decrease in the number of Nosema apis and Nosema ceranae spores on days 9 and 12 of the experiment. However, the difference in the spore counts between days 9 and 12 was not statistically significant. The researchers recommended using HEOEM every 3 days for a period of at least 15 days. Due to its natural composition, HEOEM can be an alternative to artificial substances used to fight nosemosis [35].
Natural substances do not always have a positive effect on reducing the number of Nosema spp. spores. Vetiver oil derived from Vetiveria zizanoides (L.) Roberty from the Poaceae family showed no significant properties against nosemosis. Furthermore, it caused a rapid increase in the Nosema infection rates between days 19 and 25 of the experiment [36].
Generally, EOs can be natural competitors to fumagillin in nosemosis treatment. However, they do not seem to outweigh fumagillin effectiveness in any type of treatment.

2.2. Plant Extracts

Plant extracts were successfully used to treat N. ceranae infection, similarly to EOs. Very promising agents tested both in the laboratory and in the apiary were adaptogenic plant extracts, especially from Eleutherococcus senticosus (Rupr. et Maxim.) Maxim. roots. These extracts reduced the nosemosis level, prolonged the honeybee lifespan, and can be used in prophylaxis of nosemosis [37,38].
Extract from Laurus nobilis L. (laurel) applied at a 1% concentration reduced the N. ceranae spore load [39]. After 17 days of treatment, Artemisia absinthium L. extract inhibited development of N. apis in both naturally and artificially infected worker honeybees in laboratory conditions. However, it is worth noting that honeybee mortality was also increased [40]. Only extracts from two representatives of the Compositae family, Artemisia dubia (Wall.) and Aster scaber (Thunb.) Nees, exerted an anti-nosemosis effect [41]. Other tested extracts did not show anti-nosemosis activity. These inefficient extracts were derived from Amaranthus mango-stanys L., Mentha arvensis L., Allium senescens L. var. senescens, Astilboides tabularis (Hemsl.) Engl., Veratrum oxysepalum Turcz., Achyranthes japonica (Miq.) Nakai, Lythrum salicaria L., Symphytum officinale L., Schisandra chinensis (Turcz.) Baill., Perilla frutescens var. acuta Kudo, Physalis alkekengi var. francheti (Mast.) Hort, Rheum undulatum L., Aster scaber Thunberg, Cirsium nipponicum (Maxim.) Makino, Achillea alpina (Ledeb), Disporum uniflorum Baker, Astragalus membranaceus Bunge var. membranaceus, Aster tataricus L.f., and Artemisia dubia (Wall.).
A decoction of a Chinese herb Andrographis paniculat (Burm.f.) Nees administered at a 1% concentration supported epithelium tissue regeneration during N. ceranae infection and reduced the number of Nosema spores. Other herbs used in this experiment, i.e., Cyrtomium fortune J. Sm., Cinnamomum cassia (L.) J.Presl, and Eucalyptus citridora (Hook.) K.D. Hill & L.A.S.Johnson, seemed to be useless for controlling N. ceranae infection, as they increased honeybee mortality, compared to the control group, in laboratory conditions [42]. Allium sativum L. (garlic) extract applied at a 1% concentration produced no differences in comparison with the control group. On the other hand, its higher concentration (10%) was highly toxic to honeybees [38]. In turn, Origanum vulgare L. and Rosmarinus officinalis L. extracts administered at a concentration of 0.7%, and volatile oils exhibited anti-nosemosis properties by reducing spore loads in laboratory conditions [43].
Another plant with activity against nosemosis is Lespedeza cuneata. It is an invasive plant displacing native species in many countries and occupying their habitats. The aim of the laboratory experiments conducted by Song et al. [44] was to test the effect of L. cuneata extract used at concentrations from 12.5 µg/mL to 800 µg/mL against N. ceranae using the Trichoplusia ni cell line BTI-TN5B1-4, which is an alternative cell line to honeybee cells. Infected cells were degraded and had a larger, abnormal shape compared to healthy cells with a round and correct shape. When treated with the L. cuneata extract, the infected cells were similar in shape to the healthy cells, and most of the spores were outside the cell. In addition, the researchers were able to determine the lowest concentration that inhibited the development of nosemosis, i.e., 50 µg/mL, and the highest concentration: 200 µg/mL, which did not cause adverse effects [44].
In laboratory experiments conducted by Braglia et al. [44], the inhibitory effect of, e.g., Opuntia ficus-indica extracts against the development of nosemosis was checked. The extract was administered to honeybees at a concentration of 0.005 µL/mL of sugar syrup (1:1 w:v). The study showed that the extract enhanced the development of nosemosis and was toxic to honeybees, as evidence by the death of all honeybees by the 9th day of the experiment [45].

2.3. Thymol

Another compound studied in a laboratory was thymol, which reduced the development of N. ceranae at a concentration of 0.1 mg per 1 g of honeybee candy or sugar syrup. Similar results can be found in other studies, for example conducted by Yucel and Dogaroglu [46], Maistrello et al. [36], or Borges et al. [47]. Honeybees fed with thymol (0.12 mg/g) and resveratrol (0.001 mg/g) candies exhibited a lower N. ceranae infection level [47]. Additionally, honeybees fed with thymol or resveratrol syrup lived longer than those in the control group. However, pure resveratrol did not decrease the N. ceranae spore load [47,48].
In apiary experiments conducted by Vargas-Valero et al. [49], Nosema ceranae-infected honeybee colonies kept in the tropical conditions of Yucatan, Mexico, were administered a thymol solution at a concentration of 66 mg of thymol crystals per 1 L of sugar syrup or fumagillin at a concentration of 25.2 mg per 1 L of sugar syrup. The administration of the thymol solution proved to be effective in 31.1%, compared to fumagillin, whose effectiveness was 95.2%. In the control group, the nosemosis level decreased after 4 weeks, but this may have been a result of seasonal variations in the nosemosis level. Therefore, further trials using thymol as an alternative antifungal agent are needed [49].

2.4. Natural Polysaccharide

Chitosan is a linear polysaccharide obtained by deacetylation of chitin. Due to its beneficial properties (e.g., biocompatibility, biodegradability, hydrophilicity, nontoxicity, high bioavailability), it seems to be a safe and promising anti-nosemosis compound [50]. Sugar syrup containing 0.01% chitosan decreased the severity of infection with N. apis and increased the expression of AMP and vitellogenin genes in apiary conditions [1,47]. Additionally, chitosan prolonged the honeybee lifespan [51,52].

2.5. Honeybee Product—Propolis

Propolis has many beneficial properties and may also be helpful in treatment of honeybees. It composition depends on plant species available for forager honeybees [53]. Propolis contains many compounds, e.g., flavonoids, aromatic acids, esters, aldehydes, ketones, fatty acids, terpenes, steroids, amino acids, polysaccharides, hydrocarbons, alcohols, hydroxybenzene, caffeic acid, ferulic acid, ellagic acid, quercetin, and others [53]. The propolis ethanol extract administered orally to Nosema-infected honeybees significantly reduced the nosemosis level in laboratory conditions [54,55,56]. Furthermore, propolis produced by Trigona apicalis Smith, one of the stingless bee species, significantly reduced the N. ceranae infection level and mortality in Apis florea and Apis cerana colonies [53,57,58]. However, propolis preparations also pose some threats to honeybees, as they can be a source of pesticide contamination [54,56].

2.6. Probiotics

The first laboratory experiments using gut bacteria isolated from the intestines of healthy honeybees, i.e., bifidobacteria and lactobacilii, were carried out by Baffoni et al. [59]. Laboratory tests using the real-time PCR method proved that the nosemosis level in healthy and infected honeybees fed with gut bacteria was significantly lower than in the control, i.e., honeybees fed only with sugar syrup. Subsequent studies showed that the oral administration of bacterial metabolites produced by Lactobacillus johnsonii and L. kunkeei strains did not have a toxic effect on honeybees but reduced the nosemosis level [60,61]. Similar results can be found in a study conducted by Audisio et al. [54], in which honeybee colonies were fed Lactobacillus johnsonii CRL1647 in the amount of 1 × 105 cfu/mL every 15 days and monthly. The study showed that both methods of administration of the preparation increased honey production and reduced nosemosis. In the case of varroosis, it was observed that administration of lactobacilli once a month reduced the development of the disease [62].
Additionally, organic acids produced by Lactobacillus johnsonii CRL 1647 had a positive effect on honeybee colonies and reduced nosemosis development. Additionally, in vitro administration of cell-free supernatants from L. johnsonii containing mainly organic acids such as lactic acid, phenyl-lactic acid, and acetic acid did not cause honeybee mortality even at a high dose of 60 µL/ honeybee [63]. Furthermore, such metabolites as bactericin and surfactin derived from Bacillus strains inhibited the development of nosemosis [64].
On the other hand, honeybees fed with Lactobacillus rhamnosus showed a higher nosemosis level and a shorten lifespan in comparison to the control group fed only sugar syrup [65].
Therefore, it should be emphasised that supplementation of honeybees’ diet with improperly selected bacteria not dedicated for honeybees does not prevent nosemosis development but may increase its level, deregulate insect immune systems, and significantly increase honeybee mortality [65,66].
A metagenomic analysis of honeybee colonies from the UK, Spain, Poland, Greece, and Thailand proved that nosemosis caused higher loads of fungi and such bacterial groups as Firmicutes (Lactobacillus), γ-proteobacteria, and Neisseriaceae, whereas healthy honeybees had a higher load of such bacterial groups as Orbales, Gilliamella, Snodgrassella, and Enterobacteriaceae [67,68]. Nosemosis infection also caused a higher abundance of Bifidobacterium spp. in infected honeybees [69].

2.7. Fungal Extract

Fungal extracts obtained from the Agaricus genus were also used in the control of nosemosis due to their content of biologically active compounds, e.g., glucans, mannan, and lentinan with immunostimulatory effects [70]. In laboratory experiments carried out by Glavinic et al. [71], the influence of aqueous extracts of Agaricus bisporus on honeybee survival, the degree of nosemosis infection, and the level of expression of genes related to honeybee immunity, i.e., abacin, defensin, hymenoptecin, apidicin, and vitellogenin, was determined. The concentration of 200 µg/g was selected for further analyses due to its lowest toxicity to honeybees. The researchers observed a decrease in the number of N. ceranae spores when the A. bisporus extract was administered to the honeybees. Moreover, the infected honeybees had a prolonged lifespan [71].

2.8. Other Natural Substances

Aqueous extracts of jet-black ant Lasius fuliginosus nests in laboratory experiments decreased the nosemosis level. It was found that the administration of carton extract (birch) at concentrations of 0.1% and 1% for 6 days caused an 18-fold decrease in Nosema spp. spores, compared to the control group, i.e., honeybees fed only with sugar syrup. Moreover, the extract had a protective effect on healthy honeybees by increasing their lifespan [72].

3. Synthetic Substances

3.1. Phytochemicals

In addition to substances of natural origin, many chemically synthesised substances were used for nosemosis treatment [73,74]. Bernklau et al. [74] conducted laboratory experiments on honeybees using phytochemicals, i.e., caffeic, gallic, and p-coumaric acids and kaempferol. Caffeic acid at 25 ppm, gallic acid at 250 ppm, and kaempferol at 2500 ppm prolonged the honeybee lifespan most effectively. Caffeic acid at the highest concentration of 2500 ppm reduced the honeybee lifespan. A reduction in the N. ceranae spore load was observed during simultaneous administration of caffeic and p-coumaric acids and kaempferol at the concentration of 25 ppm. However, pure kaempferol reduced the amount of spores in all concentrations [74]. Braglia et al. [17] showed in laboratory conditions that p-coumaric acid at a concentration of 31 ppm inhibited the development of nosemosis in winter honeybees. In turn, in the study conducted by Bernklau et al. [74], this acid at a concentration of 25 ppm limited the development of the disease in summer honeybees.
Another tested compound was sulforaphane obtained from cruciferous vegetables. At concentrations of 0.1250 mg/mL and 0.1667 mg/mL, it caused a substantial decrease in the N. ceranae spore load. At a concentration of 1.2500 mg/mL, it caused higher honeybee mortality but eradicated nosemosis [47]. Additionally, carvacrol from oregano oil effectively reduced Nosema spore loads in a dose of 0.1000 mg/mL of sugar syrup. In turn, naringenin from citrus fruit had a moderate effect on reducing Nosema spore loads, and its main advantage was the extension of the honeybee lifespan [47].
Caffeine is one of the purine alkaloids naturally occurring in plant species from the Camellia L., Coffea L., Theobroma L., Paullinia Kunth, Ilex L., and Cola H. W. Schott et Endlicher genera [75]. A sugar solution of caffeine administered at a 5 μg/mL dose exerted a protective effect against Nosema-infection. Additionally, honeybees fed with a caffeine solution were found to live longer than honeybees fed pure sugar syrup in the control group [76], likewise workers treated with curcumin [77] and piperine [78].
Nicotine is not an effective anti-nosemosis substance and, in a dose of 1 ppm, was not preferentially consumed by honeybee foragers. Higher concentrations of nicotine up to 104 ppm also showed no healing properties. At high concentrations, nicotine increased honeybee mortality. In vitro studies showed that spores treated with nicotine remained infectious to honeybees [79].

3.2. Organic Compounds

Other compounds tested to eliminate nosemosis were oxalic, formic, and abscisic acids, which are commonly used by beekeepers to control another disease affecting honeybees, i.e., varroosis caused by Varroa destructor [80,81]. After spraying Nosema-infected honeybees with oxalic acid, a reduction in the nosemosis level was observed [80,82]. Fumigation with formic acid also decreased N. apis and N. ceranae spore loads during overwintering [81,83]. The effect of abscisic acid (ABA) applied at a concentration of 50 μM in sugar syrup or honey preserved the initial adult worker population after the winter and, to a small extent, decreased the nosemosis level. Additionally, in both sugar-fed and honey-fed honeybees, much slower development of the disease was observed, compared to control groups that did not receive ABA in apiary conditions [3].
A similar experiment was carried out by researchers from the University of Uppsala, who tested the impact of 0.2% and 0.4% acetic acid and 0.03% benzoic acid on the development of nosemosis in laboratory and natural (apiary) conditions. In this experiment, it was shown that the administration of a 10 μL solution of these compounds in sugar syrup did not affect the spread and development of the Nosema disease [84].
Porphyrins are promising agents in combating nosemosis. These aromatic heterocyclic compounds were another group of compounds used in honeybee supplementation to suppress the development of nosemosis. Honeybees treated with sugar syrup containing synthetic amphiphilic protoporphyrin amide [PP (Asp) 2] had a decreased number of Nosema spp. spore loads in laboratory conditions. PP (Asp) 2 has also been shown to reduce the mortality of infected honeybees. Furthermore, incubation of Nosema spores with the porphyrin reduced their infection effectivity [85]. In the future, porphyrins may play the role of antibiotics, as they show activity against many microorganisms, e.g., fungi, protozoa, bacteria, and viruses [86].

3.3. Alcohol

Another chemical compound tested in laboratory conditions was ethanol. Surprisingly, the amount of Nosema spp. spores in infected honeybees treated with 5% ethanol increased significantly compared to the control group and caused higher honeybee mortality [87]. In addition, the administration of 10% ethanol in sugar syrup had a toxic effect on both healthy and Nosema-infected honeybees. The administration of this compound probably caused immune suppression in the honeybees, which consequently led to an increase in the nosemosis level. Ethanol may also enable Nosema spores to enter the honeybee intestine and facilitate the infection [87].

3.4. Commercial Preparations

Another substance obtained synthetically is PROVIGOR 14 WA Bee Care®. Its effectiveness is related to the content of bioflavonoids combined with many natural acids, e.g., lactic and ascorbic acids. Honeybee colonies were sprayed twice a week with sugar syrup containing 1 mL of PROVIGOR per 1000 mL of syrup, and a significant reduction in the Nosema spore load was observed after 10 such doses. However, the disease was not completely eradicated [88].
The effect of amprolium hydrochloride on Nosema disease development was also investigated. It is a veterinary medicine used as an antiprotozoal agent (coccidiostatic). This drug interferes with thiamine metabolism and has a similar structure to vitamin B12. Amprolium hydrochloride was administered to honeybees at two concentrations: 200 ppm and 1000 ppm. The experiment was conducted for 19 days and, at the end, no spores were found in the experimental groups, while the number of spores in the control group ranged from 5.75 to 7.625 million per honeybee [89]. Both concentrations proved to be effective in fighting Nosema infection and exerted no side effects on the honeybees. According to the manufacturer’s instructions, the product should be used in the amount of 10 mg/kg of body weight for 7 days in 200 mL of sugar syrup. This dose, even after exceeding the estimated therapeutic dose five times, did not produce side effects in the honeybees. However, the time of treatment should not exceed 5–7 days because this substance may cause vitamin B1 deficiency [89].

3.5. Vitamins

A similar experiment to that with amprolium hydrochloride was carried out using B-group vitamins. In the experiment, the following parameters were checked: worker productivity, flight activity, pollen foraging efficiency, effect on egg laying, impact on honey yield, level of parasitation, and others. After 15 days, the condition of the honeybee colonies improved, but there was no effect on the Nosema spp. spore load [90].

3.6. Antibiotics

Various substances were tested on the IPL-LD 65Y cell line derived from Lymantria dispar, which was found to be sensitive to infection with Nosema spp. Cell cultures infected with Nosema spp. spores were treated with fumagillin as a positive control and with the tested substances, i.e., surfactin, metronidazole, ornidazole, quinine, tinidazole, albendazole, and dimethyl sulfoxide (DMSO). The results of the laboratory experiment showed that antibiotics from the nitroimidazole group, i.e., metronidazole and tinidazole, inhibited the proliferation of N. ceranae. However, the other substances did not affect the development of the disease [91].

3.7. RNA Interference

RNA interference (RNAi) is used in anti-nosemosis therapy as well. RNAi is a post transcriptional gene silencing mechanism and a natural anti-infective mechanism of the honeybee immune response [92,93]. When workers ingested daily doses of synthetic dsRNA (in sugar syrup) specific to N. ceranae ATP/ADP transporters, the target transcript levels and the Nosema spore loads decreased [81]. RNAi is also used to lower the expression of polar tube protein 3 (ptp3), i.e., a protein essential for sporoplasm injection and microsporidian cellular invasion [93]. When the expression of ptp3 was decreased, spore loads decreased, several antimicrobial peptides (abaecin, apidaecin, hymenoptaecin, defensin-1) increased in the hemolymph of workers, and the honeybee lifespan was significantly prolonged [81,93]. Following the ingestion of dsRNA targeting the naked cuticle gene (nkd; regulator of immune function in honeybees), lower infection levels and increased immune expression and survival in honeybees were observed [94]. When administering RNAi to honeybees, the action of digestive enzymes and intestinal pH should be taken into account, as they can rapidly metabolize the drug and change its sequence, thereby reducing the efficiency and stability of RNAi [81].

4. Conclusions

Similar to other pollinators, honeybees are in danger of extinction [1]. Nosemosis is a very dangerous honeybee disease affecting honeybee physiology and biology. It negatively alters the gut epithelium renewal rate. Mature spores create a layer of spores on the intestine surface, which affects midgut integrity and deteriorates the physiological function of the honeybee alimentary tract [15,95,96]. Furthermore, Nosema–infection changes the content of macro- and microelements in honeybees, which disrupts honeybee physiology [15,97]. All these factors lead to higher mortality rates and a decline in honeybee populations. Among the natural substances presented in this review paper, the essential oils of adaptogenic plant extracts, Supresor1, and propolis had the best effect in limiting the development of nosemosis. Among the synthetic substances, promising treatment outcomes were obtained with the use of porphyrins, caffeic acid, and kaempferol administered at appropriate concentrations. Preparations based on synthetic substances have a strictly defined composition, compared to natural substances, whose composition may vary depending on the plant growth locality or the plant collection season. Regardless of the origin of the substance, the key factor is the correct determination of the minimum dose that shows the highest level of inhibition of nosemosis. In addition, an important issue is to determine the duration of the treatment and the frequency of administration of these substances [36]. An excessive dose of the compound very often leads to an increase in honeybee mortality, e.g., administration of 10% garlic extract and 5% ethanol increased honeybee mortality very rapidly. Moreover, the tested compounds should not penetrate and accumulate in honeybee products because this may lead to a change in the flavour of these products and, in the worst case, pose a risk to consumers. Therefore, searching for new agents to prevent and treat nosemosis is an urgent issue, as it is essential to help the honeybee survive.

Author Contributions

M.K.-B. prepared the manuscript, especially the part on the natural and synthetic substances, and the Nosema spp. life cycle scheme (Figure 1); M.B. prepared the manuscript, especially the part on the synthetic substances, and the Nosema spp. life cycle scheme (Figure 1); M.S. and A.S. prepared the manuscript, especially the part on the natural substances; A.A.P. prepared the manuscript, especially the part on nosemosis; A.A.P. (a senior author) prepared the complete manuscript and revised version. A.A.P., M.K.-B., M.B., A.S., M.G. and R.R. contributed to the interpretation of results and writing of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

The first draft of the manuscript contained a fragment written in Polish by Maciej Bryś. This fragment was removed as redundant before sending the work for review in this respected journal. However, the authors would like to thank M. Brys for his contribution to the preliminary version of this work.

Conflicts of Interest

None of the authors of this paper has a financial or personal relationship with other people or organisations that could inappropriately influence or bias the content of the paper.

References

  1. Ptaszyńska, A.A. A Short Guide to the Sixth Mass Extinction—Is the Anthropocene an Extended Suicide? Rev. Educ. 2022, 395, 27–41. Available online: https://revistaeducacion.org/EDU/journals/published/1628853580_j47Wb.pdf (accessed on 10 October 2022).
  2. Cornara, L.; Biagi, M.; Xiao, J.; Burlando, B. Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Front. Pharmacol. 2017, 8, 412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Szawarski, N.; Saez, A.; Dominguez, E.; Dickson, R.; de Matteis, A.; Eciolaza, C.; Justel, M.; Aliano, A.; Solar, P.; Bergara, I.; et al. Effect of Abscisic Acid (ABA) Combined with Two Different Beekeeping Nutritional Strategies to Confront Overwintering: Studies on Honeybees’ Population Dynamics and Nosemosis. Insects 2019, 10, 329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Oleksa, A.; Burczyk, J. Markery DNA w hodowli zachowawczej rodzimych linii pszczoły miodnej. Wiad. Zootech. 2010, 1, 55–67. [Google Scholar]
  5. Alonso-Prados, E.; Muñoz, I.; de la Rúa, P.; Serrano, J.; Fernández-Alba, A.R.; García-Valcárcel, A.I.; Hernando, M.D.; Alonso, A.; Alonso-Prados, J.L.; Bartolomé, C.; et al. The toxic unit approach as a risk indicator in honeybees surveillance programmes: A case of study in Apis mellifera iberiensis. Sci. Total Environ. 2019, 698, 134208. [Google Scholar] [CrossRef]
  6. Alaux, C.; Brunet, J.L.; Dussaubat, C.; Mondet, F.; Tchamitchan, S.; Cousin, M.; Brillard, J.; Baldy, A.; Belzunces, L.P.; Le Conte, Y. Interactions between Nosema microspores and a neonicotinoid weaken honeybees (Apis mellifera). Environ. Microbiol. 2010, 12, 774–782. [Google Scholar] [CrossRef] [Green Version]
  7. Wittner, M.; Weiss, L.M. The Microsporidia and Microsporidiosis; ASM Press: Washington, DC, USA, 1999. [Google Scholar]
  8. Zander, E. Tierische Parasiten als Krankheitserreger bei der Biene. Münch. Bienenz. 1909, 31, 196–204. [Google Scholar]
  9. Fries, I.; Martín, R.; Meana, A.; García-Palencia, P.; Higes, M. Natural infections of Nosema ceranae in European honey bees. J. Apic. Res. 2006, 45, 230–233. [Google Scholar] [CrossRef]
  10. Chemurot, M.; Smet, L.; Brunain, M.; de Rycke, R.; de Graaf, D.C. Nosema neumanni n. sp. (Microsporidia, Nosematidae), a new microsporidian parasite of honeybees, Apis mellifera in Uganda. Eur. J. Protistol. 2017, 61, 13–19. [Google Scholar] [CrossRef]
  11. Soklič, M.; Gregorc, A. Comparison of the two microsporidia that infect honeybees—A review. Agricultura 2016, 13, 49–56. [Google Scholar] [CrossRef] [Green Version]
  12. Fries, I.; Feng, F.; Da Silva, A.; Slemenda, S.B.; Pieniazek, N.J. Nosema ceranae n. sp. (Microspora, Nosematidae), morphological and molecular characterization of a microsporidian parasite of the Asian honey bee Apis cerana (Hymenoptera, Apidae). Eur. J. Protistol. 1996, 32, 356–365. [Google Scholar] [CrossRef]
  13. Huang, W.F.; Jiang, J.H.; Chen, Y.W.; Wang, C.H. Nosema ceranae infection in Apis mellifera. In Proceedings of the 38th Annual Meeting of the Society for Invertebrate Pathology, Anchorage, AK, USA, 7–11 August 2005. [Google Scholar]
  14. Goblirsch, M. Nosema ceranae disease of the honeybee (Apis mellifera). Apidologie 2017, 49, 131–150. [Google Scholar] [CrossRef] [Green Version]
  15. Ptaszyńska, A.A.; Borsuk, G.; Mułenko, W.; Demetraki-Paleolog, J. Differentiation of Nosema apis and Nosema ceranae spores under Scanning Electron Microscopy (SEM). J. Apic. Res. 2014, 53, 537–544. [Google Scholar] [CrossRef]
  16. Tauber, J.; Nguyen, V.; Lopez, D.L.; Evans, J. Effects of a Resident Yeast from the Honeybee Gut on Immunity, Microbiota, and Nosema Disease. Insects 2019, 10, 296. [Google Scholar] [CrossRef] [Green Version]
  17. Solter, L.; Becnel, J.; Oi, D. Microsporidian Entomopathogens. In Insect Pathology; Elsevier Inc.: Amsterdam, The Netherlands, 2012; Volume 88, pp. 221–263. [Google Scholar] [CrossRef]
  18. Delbac, F.; Polonais, V. The microsporidian polar tube and its role in invasion. Subcell. Biochem. 2008, 47, 208–220. [Google Scholar] [CrossRef] [PubMed]
  19. Fries, I.; Granados, R.R.; Morse, R.A. Intracellular germination of spores of Nosema apis Z. Apidologie 1992, 23, 61–71. [Google Scholar] [CrossRef] [Green Version]
  20. Bravo, J.; Carbonell, V.; Sepúlveda, B.; Delporte, C.; Valdovinos, C.E.; Martín-Hernández, R.; Higes, M. Antifungal activity of the essential oil obtained from Cryptocarya alba against infection in honeybees by Nosema ceranae. J. Invertebr. Pathol. 2017, 149, 141–147. [Google Scholar] [CrossRef]
  21. Hanson, F.R.; Eble, T.E. An antiphage agent isolated from Aspergillus sp. J. Bacteriol. 1949, 58, 527–529. [Google Scholar] [CrossRef] [Green Version]
  22. Katznelson, H.; Jamieson, C.A. Control of nosema disease of honeybees with fumagillin. Science 1952, 115, 70–71. [Google Scholar] [CrossRef]
  23. Bailey, L. The treatment of nosema disease with fumagillin. Bee World 1953, 34, 136–137. [Google Scholar] [CrossRef]
  24. Van den Heever, J.P.; Thompson, T.S.; Curtis, J.M.; Ibrahim, A.; Pernal, S.F. Fumagillin: An overview of recent scientific advances and their significance for apiculture. J. Agric. Food Chem. 2014, 62, 2728–2737. [Google Scholar] [CrossRef] [PubMed]
  25. Williams, G.R.; Sampson, M.A.; Shutler, D.; Rogers, R.E. Does fumagillin control the recently detected invasive parasite Nosema ceranae in western honey bees (Apis mellifera)? J. Invertebr. Pathol. 2008, 99, 342–344. [Google Scholar] [CrossRef] [PubMed]
  26. Sarlo, E.G.; Medici, S.K.; Porrini, M.P.; Garrido, M.; Floris, I.; Euguaras, M.J. Comparison between different fumagillin dosage and evaluation method in the apiary control of nosemosis type C. Redia 2011, 94, 39–44. [Google Scholar]
  27. Huang, W.; Solter, L.; Yau, P.; Imai, B. Nosema ceranae escapes fumagillin control in honeybees. PLoS Pathog. 2013, 9, e1003185. [Google Scholar] [CrossRef] [Green Version]
  28. European Commission. Commission Regulation No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No. 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No. 726/2004 of the European Parliament and of the Council. Off. J. Eur. Union 2009, L152, 11–22. [Google Scholar]
  29. Raut, J.S.; Karuppayil, S.M. A status review on the medicinal properties of essential oils. Ind. Crop. Prod. 2014, 62, 250–264. [Google Scholar] [CrossRef]
  30. Dumitru, A.; Chioveanu, G.; Ionita, M.; Dobre, G.; Mitrea, I.L. “In vitro” Studies on using natural essential oils in treatment of nosemosis in honeybees: Determination of the therapeutic dose. Sci. Works Ser. C Vet. Med. 2017, 63, 165–170. [Google Scholar]
  31. Porrini, M.P.; Garrido, P.M.; Gende, L.B.; Rossini, C.; Hermida, L.; Marcángeli, J.A.; Eguaras, M.J. Oral administration of essential oils and main components: Study on honeybee survival and Nosema ceranae development. J. Apic. Res. 2017, 56, 616–624. [Google Scholar] [CrossRef]
  32. Froiio, F.; Ginot, L.; Paolino, D.; Lebaz, N.; Bentaher, A.; Fessi, H.; Elaissari, A. Essential Oils-Loaded Polymer Particles: Preparation, Characterization and Antimicrobial Property. Polymers 2019, 11, 1017. [Google Scholar] [CrossRef] [Green Version]
  33. Ahmed, M. Acute Toxicity (Lethal Dose 50 Calculation) of Herbal Drug Somina in Rats and Mice. Pharmacol. Pharm. 2015, 6, 185–189. [Google Scholar] [CrossRef] [Green Version]
  34. Arismendi, N.; Vargas, M.; López, M.D.; Barría, Y.; Zapata, N. Promising antimicrobial activity against the honeybee parasite Nosema ceranae by methanolic extracts from Chilean native plants and propolis. J. Apic. Res. 2018, 57, 522–535. [Google Scholar] [CrossRef]
  35. Özkırım, A.; Küçüközmen, B. Application of Herbal Essential Oil Extract Mixture for Honey Bees (Apis mellifera L.) against Nosema ceranae and Nosema apis. J. Apic. Sci. 2021, 65, 163–175. [Google Scholar] [CrossRef]
  36. Maistrello, L.; Lodesani, M.; Costa, C.; Leonardi, F.; Marani, G.; Caldon, M.; Mutinelli, F.; Granato, A. Screening of natural compounds for the control of nosema disease in honeybees (Apis mellifera). Apidologie 2008, 39, 436–445. [Google Scholar] [CrossRef] [Green Version]
  37. Ptaszyńska, A.A.; Załuski, D. Extracts from Eleutherococcus senticosus (Rupr. et Maxim.) Maxim. Roots: A New Hope against Honeybee Death Caused by Nosemosis. Molecules 2020, 25, 4452. [Google Scholar] [CrossRef]
  38. Porrini, M.P.; Fernández, N.J.; Garrido, P.M.; Gende, L.B.; Medici, S.K.; Eguaras, M.J. In vivo evaluation of antiparasitic activity of plant extracts on Nosema ceranae (Microsporidia). Apidologie 2011, 42, 700–707. [Google Scholar] [CrossRef]
  39. Damiani, N.; Fernández, N.J.; Porrini, M.P.; Gende, L.B.; Álvarez, E.; Buffa, F.; Brasesco, C.; Maggi, M.D.; Marcangeli, J.A.; Eguaras, M.J. Laurel leaf extracts for honeybee pest and disease management: Antimicrobial, microsporicidal, and acaricidal activity. Parasitol. Res. 2014, 113, 701–709. [Google Scholar] [CrossRef]
  40. Pohorecka, K. Laboratory studies on the effect of standardized Artemisia absinthium L. extract on Nosema apis infection in the worker Apis mellifera. J. Apic. Sci. 2004, 48, 131–136. [Google Scholar]
  41. Kim, J.H.; Park, J.K.; Lee, J.K. Evaluation of antimicrosporidian activity of plant extracts on Nosema ceranae. J. Apic. Sci. 2016, 60, 167–178. [Google Scholar] [CrossRef] [Green Version]
  42. Chen, X.; Wang, S.; Xu, Y.; Gong, H.; Wu, Y.; Chen, Y.; Zheng, H. Protective potential of Chinese herbal extracts against microsporidian Nosema ceranae, an emergent pathogen of western honeybees, Apis mellifera L. J. Asia-Pac. Entomol. 2019, 24, 502–512. [Google Scholar] [CrossRef]
  43. Radoi, I.; Sapcaliu, A.; Mateescu, C.; Pop, A.; Savu, V. In vitro screening of hydroalcoholic plant extracts to control Nosema apis infection. J. Biotechnol. 2014, 185, S46. [Google Scholar] [CrossRef]
  44. Song, H.; Kim, H.; Kim, K. Anti-Parasitic Activity of Lespedeza cuneata Extract on Causative Agent of Nosemosis Type C, Nosema ceranae. J. Apic. 2019, 34, 137–140. [Google Scholar] [CrossRef]
  45. Braglia, C.; Alberoni, D.; Porrini, M.P.; Garrido, P.M.; Baffoni, L.; Di Gioia, D. Screening of Dietary Ingredients against the Honey Bee Parasite Nosema ceranae. Pathogens 2021, 10, 1117. [Google Scholar] [CrossRef] [PubMed]
  46. Yucel, B.; Dogaroglu, M. The Impact of Nosema apis Z. Infestation of Honey Bee (Apis mellifera L.) Colonies after Using Different Treatment Methods and their Effects on the Population Levels of Workers and Honey Production on Consecutive Years. Pak. J. Biol. Sci. 2005, 8, 1142–1145. [Google Scholar] [CrossRef] [Green Version]
  47. Borges, D.; Guzman-Novoa, E.; Goodwin, P.H. Control of the microsporidian parasite Nosema ceranae in honeybees (Apis mellifera) using nutraceutical and immuno-stimulatory compounds. PLoS ONE 2020, 15, e0227484. [Google Scholar] [CrossRef] [PubMed]
  48. Costa, C.; Lodesani, M.; Maistrello, L. Effect of thymol and resveratrol administered with candy or syrup on the development of Nosema ceranae and on the longevity of honeybees (Apis mellifera L.) in laboratory conditions. Apidologie 2010, 41, 141–150. [Google Scholar] [CrossRef] [Green Version]
  49. Vargas-Valero, A.; Barrientos-Medina, R.C.; Medina Medina, L.A. Efficacy of thymol in control of the fungus Nosema ceranae in Africanized Apis mellifera. Rev. Mex. Cienc. Pecu. 2021, 12, 633–643. [Google Scholar] [CrossRef]
  50. Shariatinia, Z. Pharmaceutical applications of chitosan. Adv. Colloid Interface Sci. 2019, 263, 131–194. [Google Scholar] [CrossRef]
  51. Saltykova, E.S.; Gaifullina, L.R.; Kaskinova, M.D.; Gataullin, A.R.; Matniyazov, R.T.; Poskryakov, A.V.; Nikolenko, A.G. Effect of chitosan on development of Nosema apis microsporidia in honeybees. Microbiology 2018, 87, 738–743. [Google Scholar] [CrossRef]
  52. Formato, G.; Rivera-Gomis, J.; Bubnic, J.; Martin-Hernandez, R.; Milito, M.; Croppi, S.; Higes, M. Nosemosis prevention and control. Appl. Sci. 2022, 12, 783. [Google Scholar] [CrossRef]
  53. Suwannapong, G.; Maksong, S.; Benbow, M.E. Stingless bee propolis effects on experimental infection of Apis florea with Nosema ceranae. J. Agric. Sci. Technol. A 2011, 1, 818–825. [Google Scholar] [CrossRef]
  54. Simone-Finstrom, M.; Spivak, M. Propolis and bee health: The natural history and significance of resin use by honeybees. Apidologie 2010, 41, 295–311. [Google Scholar] [CrossRef] [Green Version]
  55. Simone-Finstrom, M.; Borba, R.S.; Wilson, M.; Spivak, M. Propolis counteracts some threats to honeybee health. Insects 2017, 8, 46. [Google Scholar] [CrossRef] [Green Version]
  56. Mura, A.; Pusceddu, M.; Theodorou, P.; Angioni, A.; Floris, I.; Paxton, R.J.; Satta, A. Propolis Consumption Reduces Nosema ceranae Infection of European Honeybees (Apis mellifera). Insects 2020, 11, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Borba, R.S.; Klyczek, K.K.; Mogen, K.L.; Spivak, M. Seasonal benefits of a natural propolis envelope to honeybee immunity and colony health. J. Exp. Biol. 2015, 218, 3689–3699. [Google Scholar] [CrossRef] [Green Version]
  58. Yemor, T.; Phiancharoen, M.; Benbow, M.E.; Suwannapong, G. Effects of stingless bee propolis on Nosema ceranae infected Asian honeybees, Apis cerana. J. Apic. Res. 2015, 54, 468–473. [Google Scholar] [CrossRef]
  59. Baffoni, L.; Gaggìa, F.; Alberoni, D.; Cabbri, R.; Nanetti, A.; Biavati, B.; Di Gioia, D. Effect of dietary supplementation of Bifidobacterium and Lactobacillus strains in Apis mellifera L. against Nosema ceranae. Benef. Microbes 2016, 7, 45–51. [Google Scholar] [CrossRef]
  60. Fiorella, G.; Maggi, M.; Pellegrini, M.C.; Cugnata, N.M.; Szawarski, N.; Buffa, F.; Negri, P.; Fuselli, S.R.; Audisio, C.M.; Ruffinengo, S.R. Effects of Lactobacillus johnsonii AJ5 metabolites on nutrition, Nosema ceranae development and performance of Apis mellifera L. J. Apic. Sci. 2017, 61, 93–104. [Google Scholar] [CrossRef] [Green Version]
  61. Arredondo, D.; Castelli, L.; Porrini, M.P.; Garrido, P.M.; Eguaras, M.J.; Zunino, P.; Antúnez, K. Lactobacillus kunkeei strains decreased the infection by honeybee pathogens Paenibacillus larvae and Nosema ceranae. Benef. Microbes 2018, 9, 279–290. [Google Scholar] [CrossRef]
  62. Audisio, M.C.; Sabaté, D.C.; Benítez-Ahrendts, M.R. Effect of Lactobacillus johnsonii CRL1647 on different parameters of honeybee colonies and bacterial populations of the bee gut. Benef. Microbes 2015, 6, 687–695. [Google Scholar] [CrossRef]
  63. Maggi, M.; Negri, P.; Plischuk, S.; Szawarski, N.; de Piano, F.; de Feudis, L.; Eguaras, M.; Audisio, C. Effects of the organic acids produced by a lactic acid bacterium in Apis mellifera colony development, Nosema ceranae control and fumagillin efficiency. Vet. Microbiol. 2013, 167, 474–483. [Google Scholar] [CrossRef]
  64. Porrini, M.P.; Audisio, M.C.; Sabaté, D.C.; Ibarguren, C.; Medici, S.K.; Sarlo, E.G.; Garrido, P.M.; Eguaras, M.J. Effect of bacterial metabolites on microsporidian Nosema ceranae and on its host Apis mellifera. Parasitol. Res. 2010, 107, 381–388. [Google Scholar] [CrossRef] [PubMed]
  65. Ptaszyńska, A.A.; Borsuk, G.; Zdybicka-Barabas, A.; Cytryńska, M.; Małek, W. Are commercial probiotics and prebiotics effective in the treatment and prevention of honeybee nosemosis C? Parasitol. Res. 2016, 115, 397–406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Ptaszyńska, A.A.; Paleolog, J.; Borsuk, G. Nosema ceranae Infection Promotes Proliferation of Yeasts in Honey Bee Intestines. PLoS ONE 2016, 11, e0164477. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Ptaszyńska, A.A.; Latoch, P.; Hurd, P.J.; Polaszek, A.; Michalska-Madej, J.; Grochowalski, Ł.; Strapagiel, D.; Gnat, S.; Załuski, D.; Gancarz, M.; et al. Amplicon Sequencing of Variable 16S rRNA from Bacteria and ITS2 Regions from Fungi and Plants, Reveals Honeybee Susceptibility to Diseases Results from Their Forage Availability under Anthropogenic Landscapes. Pathogens 2021, 10, 381. [Google Scholar] [CrossRef]
  68. Gancarz, M.; Hurd, P.J.; Latoch, P.; Polaszek, A.; Michalska-Madej, J.; Grochowalski, Ł.; Strapagiel, D.; Gnat, S.; Załuski, D.; Rusinek, R.; et al. Dataset of the next-generation sequencing of variable 16S rRNA from bacteria and ITS2 regions from fungi and plants derived from honeybees kept under anthropogenic landscapes. Data Brief 2021, 36, 107019. [Google Scholar] [CrossRef]
  69. Zhang, Y.; Lu, X.; Huang, S.; Zhang, L.; Su, S.; Huang, W.F. Nosema ceranae infection enhances Bifidobacterium spp. abundances in the honeybee hindgut. Apidologie 2019, 50, 353–362. [Google Scholar] [CrossRef]
  70. Ishii, P.L.; Prado, C.K.; de Oliveira Mauro, M.; Carreira, C.M.; Mantovani, M.S.; Ribeiro, L.R.; Dichi, J.B.; Oliveira, R.J. Evaluation of Agaricus blazei in vivo for antigenotoxic, anticarcinogenic, phagocytic and immunomodulatory activities. Regul. Toxicol. Pharm. 2011, 59, 412–422. [Google Scholar] [CrossRef] [Green Version]
  71. Glavinic, U.; Rajkovic, M.; Vunduk, J.; Vejnovic, B.; Stevanovic, J.; Milenkovic, I.; Stanimirovic, Z. Effects of Agaricus bisporus Mushroom Extract on Honey Bees Infected with Nosema ceranae. Insects 2021, 7, 915. [Google Scholar] [CrossRef]
  72. Kunat, M.; Wagner, G.K.; Staniec, B.; Jaszek, M.; Matuszewska, A.; Stefaniuk, D.; Ptaszyńska, A.A. Aqueous extracts of jet-black ant Lasius fuliginosus nests for controlling nosemosis, a disease of honeybees caused by fungi of the genus Nosema. Eur. Zool. J. 2019, 87, 770–780. [Google Scholar] [CrossRef]
  73. Erler, S.; Moritz, R. Pharmacophagy and pharmacophory: Mechanisms of self-medication and disease prevention in the honeybee colony (Apis mellifera). Apidologie 2016, 47, 389–411. [Google Scholar] [CrossRef] [Green Version]
  74. Bernklau, E.; Bjostad, L.; Hogeboom, A.; Carlisle, A.; Arathi, H.S. Dietary Phytochemicals, Honeybee Longevity and Pathogen Tolerance. Insects 2018, 10, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Kato, M.; Nakayama, F. Caffeine. In Biotechnology of Natural Products; Springer: Cham, Switzerland, 2018; pp. 131–143. [Google Scholar]
  76. Strachecka, A.; Krauze, M.; Olszewski, K.; Borsuk, G.; Paleolog, J.; Merska, M.; Chobotow, J.; Bajda, M.; Grzywnowicz, K. Unexpectedly strong effect of caffeine on the vitality of western honeybees (Apis mellifera). Biochemistry 2014, 79, 1192–1201. [Google Scholar] [CrossRef] [PubMed]
  77. Strachecka, A.; Olszewski, K.; Paleolog, J. Curcumin stimulates biochemical mechanisms of Apis mellifera resistance and extends the apian lifespan. J. Apic. Sci. 2015, 59, 129–141. [Google Scholar] [CrossRef] [Green Version]
  78. Schulz, M.; Łoś, A.; Grzybek, M.; Ścibior, R.; Strachecka, A. Piperine as a new natural supplement with beneficial effects on the life-span and defence system of honeybees. J. Agric. Sci. 2019, 157, 140–149. [Google Scholar] [CrossRef]
  79. Hendriksma, H.P.; Bain, J.A.; Nguyen, N.; Nieh, J.C. Nicotine does not reduce Nosema ceranae infection in honeybees. Insectes Soc. 2020, 67, 249–259. [Google Scholar] [CrossRef]
  80. Papežíková, I.; Palíková, M.; Navrátil, S.; Heumannová, R.; Fronc, M. The effect of oxalic acid applied by sublimation on honeybee colony fitness: A comparison with amitraz. Acta Vet. 2016, 85, 255–260. [Google Scholar] [CrossRef]
  81. Burnham, A.J. Scientific Advances in Controlling Nosema ceranae (Microsporidia) Infections in Honeybees (Apis mellifera). Front. Vet. Sci. 2019, 6, 79. [Google Scholar] [CrossRef] [Green Version]
  82. Nanetti, A.; Rodriguez-García, C.; Meana, A.; Martín-Hernández, R.; Higes, M. Effect of oxalic acid on Nosema ceranae infection. Res. Vet. Sci. 2015, 102, 167–172. [Google Scholar] [CrossRef]
  83. Underwood, R.M.; Currie, R.W. Indoor winter fumigation with formic acid for control of Acarapis woodi (Acari: Tarsonemidae) and Nosema sp. disease. J. Econ. Entomol. 2009, 102, 1729–1736. [Google Scholar] [CrossRef]
  84. Forsgren, E.; Fries, I. Acidic-Benzoic Feed and Nosema Disease. J. Apic. Sci. 2005, 49, 81–88. [Google Scholar]
  85. Ptaszyńska, A.A.; Trytek, M.; Borsuk, G.; Buczek, K.; Rybicka-Jasińska, K.; Gryko, D. Porphyrins inactivate Nosema spp. microsporidia. Sci. Rep. 2018, 8, 5523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Farrell, D.J.; Robbins, M.; Rhys-Williams, W.; Love, W.G. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Int. J. Antimicrob. Agents 2010, 35, 531–536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Ptaszyńska, A.A.; Borsuk, G.; Mułenko, W.; Olszewski, K. Impact of ethanol on Nosema spp. infected bees. Med. Wet. 2013, 69, 736–740. [Google Scholar]
  88. Tsagkarakis, A.; Rokkas, C.; Katsimpoulas, I. Experimental Treatment with the Natural Water Acidifier Provigoro® for Nosema spp. Control: Preliminary Results. Adv. Entomol. 2015, 3, 83–85. [Google Scholar] [CrossRef] [Green Version]
  89. Dumitru, A.; Chioveanu, G.; Ionita, M.; Dobre, G.; Mitrea, I.L. In vitro trial on using amprolium clorhidrat to control Nosema infection in honeybees. Sci. Works Ser. C Vet. Med. 2018, 64, 111–116. [Google Scholar]
  90. Chandra, V.; Singh, K.S.; Singh, S.; Kumar, A.; Tiwari, D.K.; Sahay, R.; Maurya, R.C.; Singh, A. Management of Colony Collapse Disorder in Honeybee (Apis mellifera): A Farmer’s Friendly Approach Running Head: Management of Colony Collapse Disorder in Honeybee. Int. J. Curr. Microbiol. Appl. Sci. 2019, 8, 2557–2568. [Google Scholar] [CrossRef]
  91. Gisder, S.; Genersch, E. Identification of candidate agents active against N. ceranae infection in honeybees: Establishment of a medium throughput screening assay based on N. ceranae infected cultured cells. PLoS ONE 2015, 6, e0117200. [Google Scholar] [CrossRef]
  92. Brutscher, L.M.; Flenniken, M.L. RNAi and antiviral defense in the honey bee. J. Immunol. Res. 2015, 2015, 941897. [Google Scholar] [CrossRef] [Green Version]
  93. Rodríguez-García, C.; Evans, J.D.; Li, W.; Branchiccela, B.; Li, J.H.; Heerman, M.C.; Banmeke, O.; Zhao, Y.; Hamilton, M.; Higes, M.; et al. Nosemosis control in European honey bees Apis mellifera by silencing the gene encoding Nosema ceranae polar tube protein 3. J. Exp. Biol. 2018, 2018, 184606. [Google Scholar] [CrossRef]
  94. Chaimanee, V.; Chantawannakul, P.; Chen, Y.; Evans, J.D.; Pettis, J.S. Differential expression of immune genes of adult honey bee (Apis mellifera) after inoculated by Nosema ceranae. J. Insect Physiol. 2012, 58, 1090–1095. [Google Scholar] [CrossRef]
  95. Panek, J.; Paris, L.; Roriz, D.; Mone, A.; Dubuffet, A.; Delbac, F.; Diogon, M.; El Alaoui, H. Impact of the microsporidian Nosema ceranae on the gut epithelium renewal of the honeybee, Apis mellifera. J. Invertebr. Pathol. 2018, 159, 121–128. [Google Scholar] [CrossRef] [PubMed]
  96. Paris, L.; El Alaoui, H.; Delbac, F.; Diogon, M. Effects of the gut parasite Nosema ceranae on honey bee physiology and behavior. Curr. Opin. Insect Sci. 2018, 26, 149–154. [Google Scholar] [CrossRef] [PubMed]
  97. Ptaszyńska, A.A.; Gancarz, M.; Hurd, P.J.; Borsuk, G.; Wiącek, D.; Nawrocka, A.; Strachecka, A.; Załuski, D.; Paleolog, J. Changes in the bioelement content of summer and winter western honeybees (Apis mellifera) induced by Nosema ceranae infection. PLoS ONE 2018, 13, e0200410. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Life cycle of Nosema spp. Infection with nosemosis occurs through the ingestion of spores. In the intestine, during germination the spore discharges the polar tube, through which the infected sporoplasm is injected into the cytoplasm of the midgut epithelial cells. The sporoplasm then increases its volume and transforms into a meront. The next stage of development is the stage of sporogony, which is the transformation of meronts into sporonts surrounded by the cell membrane. Next, the sporonts divide into two sporoblasts, which in turn mature into spores. The spores germinate and infect other cells in the intestine of the same honeybee or are expelled outside with faeces and can infect other honeybees.
Figure 1. Life cycle of Nosema spp. Infection with nosemosis occurs through the ingestion of spores. In the intestine, during germination the spore discharges the polar tube, through which the infected sporoplasm is injected into the cytoplasm of the midgut epithelial cells. The sporoplasm then increases its volume and transforms into a meront. The next stage of development is the stage of sporogony, which is the transformation of meronts into sporonts surrounded by the cell membrane. Next, the sporonts divide into two sporoblasts, which in turn mature into spores. The spores germinate and infect other cells in the intestine of the same honeybee or are expelled outside with faeces and can infect other honeybees.
Pathogens 11 01269 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kunat-Budzyńska, M.; Budzyński, M.; Schulz, M.; Strachecka, A.; Gancarz, M.; Rusinek, R.; Ptaszyńska, A.A. Natural Substances, Probiotics, and Synthetic Agents in the Treatment and Prevention of Honeybee Nosemosis. Pathogens 2022, 11, 1269. https://doi.org/10.3390/pathogens11111269

AMA Style

Kunat-Budzyńska M, Budzyński M, Schulz M, Strachecka A, Gancarz M, Rusinek R, Ptaszyńska AA. Natural Substances, Probiotics, and Synthetic Agents in the Treatment and Prevention of Honeybee Nosemosis. Pathogens. 2022; 11(11):1269. https://doi.org/10.3390/pathogens11111269

Chicago/Turabian Style

Kunat-Budzyńska, Magdalena, Michał Budzyński, Michał Schulz, Aneta Strachecka, Marek Gancarz, Robert Rusinek, and Aneta A. Ptaszyńska. 2022. "Natural Substances, Probiotics, and Synthetic Agents in the Treatment and Prevention of Honeybee Nosemosis" Pathogens 11, no. 11: 1269. https://doi.org/10.3390/pathogens11111269

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop